| |
 |
| |
Mantra
for Indian Pharma Industry - take Incentives for new innovative pharmaceutical
products |
Mr.
Ray has around thirty years of national and international experience
in the Healthcare Industry with Pharmaceuticals, Medical Diagnostics,
Biotech, Neutraceutical/Cosmeceutical, Nutritional and Hospital Products
business, based in India and the UK. Introduction of the concept
of Drugs Price monitoring, implementation of TRIPS and establishing
Central Drugs Authority (CDA) will facilitate Indian Pharmaceutical
industry to be world leader says Mr. Ray in an exclusive interview
to Pharmaquest. |
| |
|
|
| Govt
would continue to act as a facilitator and catalyst to Pharma industry
in attaining global leadership role - Paswan |
 |
 |
| Healthcare
is one of the priority areas of the UPA government. Major commitment
is to ensure availability of life-saving essential drugs at reasonable
prices. |
| |
|
|
|
|
|
| |
| |
| |
| |
|
|
 |
|
|
China
an attractive destination for R&D
|
 |
China
is becoming an increasingly competitive environment due to ongoing
price competition, and numerous Governmental price cuts. Unless manufacturers
have Chinese based manufacturing plants, which can produce, generic
drugs at low-cost, there is little financial incentive or future
prospects for any foreign companies in the generics market.
|
|
|
| |
|
 |
Institutions
in Singapore form Technology Transfer Network
|
Technology
Transfer Network (TTN) has been formed by seven leading institutions
to co-operate on bolstering the commercialization of intellectual
property (IP) assets through the signing of a Memorandum of Understanding
(MOU).
|
|
|
 |
| Antibody
Engineering Asia |
 |
The
leading platform in Asia for sharing advancements in antibody
research 25 - 28 February 2008, Singapore IBC's first Antibody
Engineering Asia in Singapore. Antibody Engineering Asia
delivers topics from antibody research, clinical applications
to production, business development and regulatory affairs,
combining audience from all sub-sets and regions for maximum
networking and branding opportunities.
|
|
|
|
|
| |
 |
 |
India
Fast Expanding in Global Pharma Market
- Exim Bank Study |
The Indian
pharmaceutical industry today occupies a unique and fast expanding
space in the global market not only as a manufacturer of generic
drugs but also of new formulations, with growing emphasis on
research and development (R&D) and new drug discovery, says
a study by the Export Import Bank of India.
With annual turnover of over US $11 billion, the Indian pharmaceutical
industry is globally ranked 4th, in terms of volume, with a share
of 8.0 percent in the world pharmaceutical market.
|
|
 |
| Now
Liquid Drugs Under Price Cap |
|
The
National Pharmaceutical Pricing Authority (NPPA) has for
the first time brought a price cap on medicines sold in liquid
form. The authority has notified the maximum retail prices
for 16 specific medicines, including multivitamins and antibiotics,
on January 31.
Currently,
NPPA fixes the maximum retail price of specific strengths
and packs of medicines. All other medicines that contain
even a single ingredient or bulk drug under price control
are legally required to get NPPA approval.
|
 |
|
Read
More |
|
|
 |
FEEDBACK |
| Contact:
enquiry@newmediacomm.biz
New
Media Communication Pvt. Ltd., B-302, Twin Arcade, Military Road,
Marol, Andheri (E), Mumbai 400 059 India. Tel: + 91 22 29250690.
Fax: + 91 22 2925 5279.
Website: www.newmediacomm.com |
|
|
|
|
|
|
